Japan's New Prime Minister To Continue Life Science Innovation Policy
This article was originally published in PharmAsia News
Executive SummaryJapanese Prime Minister Naoto Kan said June 11 he will continue a growth policy calling for increasing life science innovation in Japan
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.